PHARMACEUTICAL AND BIOPHARMACEUTICAL PATENTS: AN OPPORTUNITY FOR FARMERGING COUNTRIES

Karina Fernandes de Oliveira, Gabriel Guerra da Silva Freire, Igor Polezi Munhoz, Alessandra Cristina Santos Akkari

Abstract


Countries with emerging pharmaceutical market (pharmerging countries) has gained prominence in the international scenario because they are identified as the future responsible for the sustainable growth of the new medicines sale. In this work, a technological and industrial mapping was developed through the analysis of patent data extracted from the Derwent World Patent Index, as well as an association with R&D reports. Pharmerging countries were not represented by the industries that most invest in R&D, nor do they stand out in patent protection, poiting to low exploitation of their markets and inexpressive innovation indices. It is suggested that the pharmerging countries adopt public policies aimed at the innovation generation, especially in the biopharmaceutical segment that has proven to have much to be explored, in order to gain a competitive advantage

Keywords


Pharmaceutical Industry, Biopharmaceutical Industry, Innovation; Pharmerging countries.



DOI: https://doi.org/10.24212/2179-3565.2018v9i3p135-148

Refbacks

  • There are currently no refbacks.


Licença Creative Commons
This Journal  is licensed under a Creative Commons Attribution - NonCommercial -Share Alike 4.0 International